Sinocare Group, a Chinese specialist in biosensor-based blood glucose monitoring devices, is expanding into the US market after agreeing to buy Nipro’s diabetes business, Nipro Diagnostics.

Mindray stock recovers from freefall after allegations that China’s leading medical device company overstated its earnings and engaged in fraudulent accounting practices.

Mindray stock recovers from freefall after allegations that China’s leading medical device company overstated its earnings and engaged in fraudulent accounting practices.

Mergers and acquisitions in China’s life sciences industry are ramping up, with some segments, such as the orthopedic device space, particularly hot. As Chinese companies rise with the market, alliance deals are increasing sharply and financing deals remain stable, according to EBI’s Strategic Transactions database.